Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06148285 · ClinicalTrials.gov registry record · NA
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
A NA study of Acute Ischemic Stroke, sponsored by LCMC Health.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06148285 is a NA study of Acute Ischemic Stroke that is actively recruiting participants, run by LCMC Health. The registered enrollment target is 120 participants, below the 347-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06148285, a NA study of Acute Ischemic Stroke, is actively recruiting participants, sponsored by LCMC Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.
Conditions Studied
Interventions
- DEVICE Hyperbaric Oxygen Therapy
Study Locations (1)
Louisiana
- Touro Infirmary New Orleans - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-05-24 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06148285
The ClinicalTrials.gov registry entry for NCT06148285 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 347-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (65% lower). The listed sponsor is LCMC Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT06148285 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06148285 about?
NCT06148285 is a clinical study titled "Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)". This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and f...
What is the current status of trial NCT06148285?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-05-24. Estimated completion is 2026-12-31.
What conditions does trial NCT06148285 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke.
What interventions are being tested in trial NCT06148285?
The interventions under investigation include: Hyperbaric Oxygen Therapy (DEVICE).
Who is sponsoring clinical trial NCT06148285?
This trial is sponsored by LCMC Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06148285 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
The Pivotal Study of RapidPulseTM Aspiration System
RECRUITING · NA
-
An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke
ACTIVE NOT RECRUITING · NA
-
Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI
ACTIVE NOT RECRUITING · NA
-
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
ACTIVE NOT RECRUITING · NA
-
Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.